JNJ-1661010 (JNJ 1661010; Takeda-25; JNJ1661010; Takeda25), a piperazinyl phenyl urea compound, is a selective and reversible inhibitor of Fatty acid amide hydrolase/FAAH with important biological activity.

WWL-154 is a novel and potent inhibitor of serine hydrolase.

BIA 10-2474 is a novel, potent, long-acting and reversible inhibitor of fatty acid amide hydrolase (FAAH) with IC50 values of 50 to 70mg/kg in various rat brain regions.

PF-3845 (PF3845; PF 3845) is a novel, biaryl ether piperidine-based, selective and covalent/irreversible inhibitor of FAAH (fatty acid amide hydrolase) with anti-inflammatory, antidiarrheal and antinociceptive effects.

LY2183240 is a novel, potent and highly potent inhibitor of FAAH (fatty acid amide hydrolase) and a blocker of anandamide uptake with IC50 of 270 pM.

JZL195 is a potent, selective and efficacious dual FAAH/MAGL (fatty acid amide hydrolase/monoacylglycerol lipase) inhibitor with IC50 of 13 nM and 19 nM for mouse brain FAAH and MAGL respectively.

PF-04457845 (PF04457845) is a novel, highly potent and selective FAAH (fatty acid amide hydrolase) inhibitor with the potential for mananing pain and other nervous system disorders.

URB597 (also known as KDS4103, URB-597; KDS-4103) is a novel, potent, selective, orally bioavailable fatty acid amide hydrolase (FAAH) inhibitor with antidepressant and analgesic activity.

Biochanin A (NSC-123538; Pratensol; NSC123538; olmelin; 4-Methylgenistein) is a novel, naturally occuring O-methylated isoflavone found in Trifolium pratense and Fabaceae plants such as clover, soy and alfalfa.

FAAH-IN-2 is a novel and potent FAAH (fatty acid amide hydrolase) inhibitor extracted from Patent WO/2008/100977A2.